Activation and blockade of serotonin4 receptors in the lateral habenula improve working memory in unilateral 6-hydroxydopamine-lesioned Parkinson's rats

Neurol Res. 2019 Jul;41(7):585-593. doi: 10.1080/01616412.2019.1596055. Epub 2019 Mar 30.

Abstract

Objective: The aim of the present study was to investigate the effects and mechanism of 6-hydroxydopamine (6-OHDA) lesions and serotonin 4 (5-HT4) receptors in the lateral habenula (LHb) on Parkinson's disease (PD) related working memory. Methods: The working memory was measured by the T-maze rewarded alternation test in sham rats and rats with unilateral 6-OHDA lesions of substantia nigra pars compacta (SNc). The concentrations of dopamine (DA), noradrenaline (NA) and 5-HT in the related brain regions were measured by neurochemistry.Results: The results showed that 6-OHDA lesions of the SNc induced working memory impairment. Intra-LHb injection of 5-HT4 receptor agonist BIMU-8 (2, 4 or 8 μg) and antagonist GR113808 (1, 3.3 or 10 μg) improved the working memory only in the lesioned rats. Intra-LHb injection of BIMU-8 (8 μg) significantly increased DA levels in the medial prefrontal cortex, dorsal hippocampus and amygdala in the lesioned rats but not in sham rats. BIMU-8 did not change NA and 5-HT levels in the related brain regions in both sham and lesioned rats. Intra-LHb injection of GR113808 (10 μg) changed DA, NA and 5-HT levels in related brain regions in both sham and the lesioned rats. In addition, the 5-HT4 receptor-positive neurons in the LHb increased significantly in the lesioned rats.Conclusion: These findings suggested that unilateral lesions of the SNc induced working memory impairment and up-regulation of 5-HT4 receptors in the LHb. Activation and blockade of LHb 5-HT4 receptors improved working memory, that were related to the change of monoamines levels. Abbreviation: 6-OHDA: 6-hydroxydopamine; serotonin:5-HT; LHb: lateral habenula; PD: Parkinson's disease; SNc: substantia nigra pars compacta; DA: dopamine; NA: noradrenaline.

Keywords: 5-HT receptor; Parkinson’s disease; lateral habenula; working memory.

MeSH terms

  • Animals
  • Benzimidazoles / administration & dosage
  • Benzimidazoles / pharmacology
  • Brain / metabolism
  • Bridged Bicyclo Compounds, Heterocyclic / administration & dosage
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Dopamine / metabolism
  • Dose-Response Relationship, Drug
  • Habenula / drug effects
  • Habenula / physiology*
  • Indoles / administration & dosage
  • Indoles / pharmacology
  • Male
  • Maze Learning / physiology
  • Memory, Short-Term / drug effects
  • Memory, Short-Term / physiology*
  • Microinjections
  • Norepinephrine / metabolism
  • Oxidopamine
  • Parkinsonian Disorders / metabolism
  • Parkinsonian Disorders / physiopathology*
  • Parkinsonian Disorders / psychology*
  • Rats
  • Receptors, Serotonin, 5-HT4 / drug effects
  • Receptors, Serotonin, 5-HT4 / metabolism
  • Receptors, Serotonin, 5-HT4 / physiology*
  • Serotonin / metabolism
  • Serotonin 5-HT4 Receptor Agonists / pharmacology
  • Serotonin 5-HT4 Receptor Antagonists / pharmacology
  • Substantia Nigra / drug effects
  • Sulfonamides / administration & dosage
  • Sulfonamides / pharmacology

Substances

  • Benzimidazoles
  • Bridged Bicyclo Compounds, Heterocyclic
  • Indoles
  • Serotonin 5-HT4 Receptor Agonists
  • Serotonin 5-HT4 Receptor Antagonists
  • Sulfonamides
  • (endo-N-8-methyl-8-azabicyclo-(3.2.1)oct-3-yl)-2,3-dihydro-3-isopropyl-2-oxo-1H-benzimidazol-1-carboxamide
  • Receptors, Serotonin, 5-HT4
  • Serotonin
  • Oxidopamine
  • Dopamine
  • Norepinephrine
  • GR 113808